` AXGN (AxoGen Inc) vs S&P 500 Comparison - Alpha Spread

AXGN
vs
S&P 500

Over the past 12 months, AXGN has significantly outperformed S&P 500, delivering a return of 144% compared to the S&P 500's 8% growth.

Stocks Performance
AXGN vs S&P 500

Loading
AXGN
S&P 500
Add Stock

Performance Gap
AXGN vs S&P 500

Loading
AXGN
S&P 500
Difference

Performance By Year
AXGN vs S&P 500

Loading
AXGN
S&P 500
Add Stock

Competitors Performance
AxoGen Inc vs Peers

AxoGen Inc
Glance View

Market Cap
713.4m USD
Industry
Health Care

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

AXGN Intrinsic Value
11.55 USD
Overvaluation 29%
Intrinsic Value
Price
Back to Top